US FDA approves Johnson & Johnson's drug for immune-mediated disorder
Health care giantJohnson & Johnson said on Wednesday the US Food and Drug Administration (FDA) has approved its drug to treat patients aged 12 years and older with an immune-mediated disorder. The drug was approved for patients with a form of …